Key result
Antiseizure medication clearance drops by up to ~50% in elderly patients, requiring lower doses.
Why the study?
Epilepsy and ASM use are common in the elderly, where aging-related physio-pathological changes and polytherapy increase the risk of altered pharmacokinetics and drug-drug interactions.
How do age-related physiological changes affect the pharmacokinetics and dosing of antiseizure medications in the elderly?
How do age-related physiological changes affect the pharmacokinetics and dosing of antiseizure medications in the elderly?
In elderly patients, antiseizure medication doses should generally be reduced and titrated slowly, with therapeutic drug monitoring to manage altered pharmacokinetics and polypharmacy risks.
Answers are grounded in this paper and cite their sources.
Warrants cautious ASM dosing in elderly; extends PK observations but leaves open randomized validation.
INTRODUCTION: Epilepsy represents the third most common neurological disorder in the elderly. Antiseizure medications (ASMs) are often used not only to treat epilepsy but also other disorders in this age group. Many physio-pathological changes occur in body composition and organ or system functions with aging. Furthermore, drug-drug interactions (DDIs) represent a major risk considering the prevalence of polytherapy in the elderly. AREAS COVERED: Relevant studies on the pharmacokinetics of ASMs in the elderly were identified through a literature search. We have reviewed all available data on known alterations in pharmacokinetic parameters of ASMs in elderly also considering pathophysiological alterations such as renal function impairment. Finally, we have highlighted the potential risk of DDIs with some drug classes. EXPERT OPINION: Large interindividual variability also due to co-morbidities and related co-therapies makes elderly patients a not homogeneous group. Overall, a reduction in loading and maintenance doses of almost all ASMs should be considered to avoid adverse events (AEs) as well as a slow titration, following the rule 'start low and go slow'. Therapeutic drug monitoring should be performed to apply the 'individual therapeutic concentration' and implemented to overcome the age-related differences between dose and plasma concentrations, to monitor DDIs and guide dosage adjustments.
No takes yet. Share an insight, caveat, or question.
Roberti et al. (2020) conducted a review in Epilepsy. Antiseizure medications was evaluated. Clearance of almost all antiseizure medications is reduced by about 20-50% in elderly patients compared with non-elderly adults, necessitating lower loading and maintenance doses.
Synapse has enriched 10 related papers. Consider them for comparative context: